CN104383314A - Medicine for treating epidemic keratitis - Google Patents
Medicine for treating epidemic keratitis Download PDFInfo
- Publication number
- CN104383314A CN104383314A CN201410588953.4A CN201410588953A CN104383314A CN 104383314 A CN104383314 A CN 104383314A CN 201410588953 A CN201410588953 A CN 201410588953A CN 104383314 A CN104383314 A CN 104383314A
- Authority
- CN
- China
- Prior art keywords
- radix
- herba
- medicine
- isatidis
- injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 54
- 229940079593 drug Drugs 0.000 title claims abstract description 21
- 206010023332 keratitis Diseases 0.000 title abstract description 7
- 238000002347 injection Methods 0.000 claims abstract description 33
- 239000007924 injection Substances 0.000 claims abstract description 33
- 239000010231 banlangen Substances 0.000 claims abstract description 20
- 241001643642 Viticis Species 0.000 claims abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 20
- 241000628997 Flos Species 0.000 claims description 19
- 239000009636 Huang Qi Substances 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 18
- 235000007351 Eleusine Nutrition 0.000 claims description 17
- 241000209215 Eleusine Species 0.000 claims description 17
- 206010010741 Conjunctivitis Diseases 0.000 claims description 13
- 238000005374 membrane filtration Methods 0.000 claims description 12
- 238000005325 percolation Methods 0.000 claims description 12
- 239000008215 water for injection Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000013521 mastic Substances 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 230000003068 static effect Effects 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 30
- 238000000034 method Methods 0.000 abstract description 8
- 244000025670 Eleusine indica Species 0.000 abstract description 2
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 235000016811 Biondella Nutrition 0.000 abstract 1
- 235000014716 Eleusine indica Nutrition 0.000 abstract 1
- 235000014266 Geum aleppicum Nutrition 0.000 abstract 1
- 241000123870 Geum aleppicum Species 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 241000904509 Mosla scabra Species 0.000 abstract 1
- 244000110797 Polygonum persicaria Species 0.000 abstract 1
- 235000004442 Polygonum persicaria Nutrition 0.000 abstract 1
- 241001530209 Swertia Species 0.000 abstract 1
- 244000010375 Talinum crassifolium Species 0.000 abstract 1
- 235000015055 Talinum crassifolium Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000002045 lasting effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 229940090044 injection Drugs 0.000 description 29
- 210000004185 liver Anatomy 0.000 description 19
- 210000001508 eye Anatomy 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 210000000232 gallbladder Anatomy 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- 210000000795 conjunctiva Anatomy 0.000 description 5
- 208000006454 hepatitis Diseases 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 231100000957 no side effect Toxicity 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000001047 pyretic effect Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 238000007910 systemic administration Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 3
- 206010008909 Chronic Hepatitis Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010052369 Encephalitis lethargica Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010020565 Hyperaemia Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 201000004484 acute conjunctivitis Diseases 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 208000013403 hyperactivity Diseases 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 201000002498 viral encephalitis Diseases 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010060891 General symptom Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010019345 Heat stroke Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010034960 Photophobia Diseases 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 206010014599 encephalitis Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 210000001165 lymph node Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000000162 simple eye Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 206010000084 Abdominal pain lower Diseases 0.000 description 1
- 206010001257 Adenoviral conjunctivitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 206010009152 Chronic tonsillitis Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000028006 Corneal injury Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019755 Hepatitis chronic active Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021750 Infantile Spasms Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000504571 Pedicularis muscicola Species 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037508 Punctate keratitis Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 208000007180 Sunstroke Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 241001312894 Trollius chinensis Species 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000009257 Visceral Prolapse Diseases 0.000 description 1
- 206010063840 Visceroptosis Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 201000004238 acute tympanitis Diseases 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 201000005547 chronic conjunctivitis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 201000001033 conjunctival folliculosis Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 208000013257 developmental and epileptic encephalopathy Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 208000021373 epidemic keratoconjunctivitis Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003560 epithelium corneal Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 208000011323 eye infectious disease Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 229940093181 glucose injection Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 230000007773 growth pattern Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000008025 hordeolum Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000022760 infectious otitis media Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 206010025226 lymphangitis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 201000005111 ocular hyperemia Diseases 0.000 description 1
- 208000001749 optic atrophy Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 201000004421 pseudomembranous conjunctivitis Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 201000003827 punctate epithelial keratoconjunctivitis Diseases 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229960000329 ribavirin Drugs 0.000 description 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 201000006476 shipyard eye Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 229940100050 virazole Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a medicine for treating epidemic keratitis. The medicine is prepared from the following raw medicines: radix bupleuri, radices sileris, cordate houttuynia, fruit of princesplume ladysthumb, trollflower, folium isatidis, radix isatidis, herba violae, astragalus membranaceus, felwort, fructus viticis, concha haliotidis, rhizoma anemarrhenae, caulis sinomenii, radix ophiopogonis, rainbow conk, eleusine indica, mosla scabra, aleppo avens and talinum crassifolium. The medicine is prepared into injection, simple in medication method, free of toxic and side effects, quickly effective, strong in effect and long in lasting time.
Description
Technical field
The present invention relates to technical field of Chinese medicine, particularly relate to a kind of medicine being used for the treatment of epidemic keratitis.
Background technology
Epidemic keratoconjunctivitis is one once pandemic eye infectious disease in the whole world.Its pathological change mainly infiltrates under acute follicular or pseudomembranous conjunctivitis and corneal epithelial cell.Primary disease, caused by adenovirus, is communicated by contact, and incubation period is 5 ~ 8 days, the morbidity of normal eyes, and start to invade simple eye, after 2 ~ 7 days, another eye is fallen ill then.From the beginning of time conjunctiva there is congestion and edema suddenly, especially obvious at semilunar fold place, have foreign body sensation, burn feeling and watery secretion; Usually occurring folliculus in morbidity the 3rd day palpebral conjunctiva, increase sharply, is that preauricular lymph nodes enlargement also has tenderness at most with upper and lower fornix portion; Fall ill after 8 ~ 10 days, there is corneal injury and with obvious photophobia, shed tears and blurred vision.
Viral keratitis is adenovirus, conventional antiviral drugs eye drip and systemic administration, but these courses of pharmaceuticals are long, poor effect, and often point turbidity under merging corneal epithelium, affects one's power of vision.
Primary disease belongs to the traditional Chinese medical science " acute and chronic conjunctivitis ", " sudden and violent nebula " category, and how attack because evil poison in season is outer, pyretic toxicity accumulates in lung liver, inside and outside combined pathogens is attacked caused by the order." Gujin Yitong Daquan, Medical Complete Book-ophthalmology " is said: suffer from eye red and swell, lacrimation and pain, or cause all pains of neck, gradually raw cataracta, cover pupil of the eye, purple does not fall apart.The etiology and pathogenesis of this disease mostly is diseases caused by exogenous pathogenic factor epidemic miasma, the high Sheng of interior double lung-fire, invades Liver Channel, above attacks and cause a disease in order.Take turns theory according to the traditional Chinese medical science five, white of the eye belongs to lung, and lung meridian has heat then hyperemia of the bulbar conjunctiva edema.Cornea and iris associating with kidney, flaming up of liver-fire is black eyeball punctate keratitis then, order gritty photophobia.This disease can simple eye or eyes occur simultaneously, and without obviously seasonal, each age group all can be fallen ill.Should based on heat-clearing and toxic substances removing, eliminating evil nebula removing in treatment.Primary disease is with obvious General Symptoms, and therefore systemic administration is real is necessary.
The present invention, based on Chinese traditional treatment theory, provides a kind of injection being used for the treatment of epidemic keratitis, adopts this administrated method simple, has no side effect, and rapid-action, effect is strong, length of holding time.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of medicine being used for the treatment of epidemic conjunctivitis, is prepared into injection, adopts this administrated method simple, has no side effect, and rapid-action, effect is strong, length of holding time.
For solving the problems of the technologies described above, the invention provides a kind of medicine being used for the treatment of epidemic conjunctivitis, its crude drug comprises Radix Bupleuri, Radix Saposhnikoviae, Herba Houttuyniae, Fructus Polygoni Orientalis, Flos Trollii, Folium Isatidis, Radix Isatidis, Herba Violae, the Radix Astragali, Radix Gentianae, Fructus Viticis, Concha Haliotidis, the Rhizoma Anemarrhenae, Caulis Sinomenii, Radix Ophiopogonis, Coriolous Dersicolor (Fr.) Quel, Herba Eleusines Indicae, Herba Moslae Soochowensis, Radix seu Herba Gei aleppici and Radix Talini Paniculati.
Wherein, in described medicine the weight of each crude drug be respectively Radix Bupleuri 20g ~ 30g, Radix Saposhnikoviae 15g ~ 25g, Herba Houttuyniae 15g ~ 25g, Fructus Polygoni Orientalis 35g ~ 45g, Flos Trollii 30g ~ 40g, Folium Isatidis 55g ~ 65g, Radix Isatidis 30g ~ 40g, Herba Violae 25g ~ 35g, Radix Astragali 25g ~ 35g, Radix Gentianae 30g ~ 40g, Fructus Viticis 10g ~ 20g, Concha Haliotidis 15g ~ 25g, Rhizoma Anemarrhenae 25g ~ 35g, Caulis Sinomenii 30g ~ 40g, Radix Ophiopogonis 25g ~ 35g, Coriolous Dersicolor (Fr.) Quel 15g ~ 25g, Herba Eleusines Indicae 15g ~ 25g, Herba Moslae Soochowensis 20g ~ 30g, Radix seu Herba Gei aleppici 30g ~ 40g and Radix Talini Paniculati 25g ~ 35g.
Wherein, in described medicine the weight of each crude drug be respectively Radix Bupleuri 23g ~ 27g, Radix Saposhnikoviae 18g ~ 22g, Herba Houttuyniae 18g ~ 22g, Fructus Polygoni Orientalis 38g ~ 42g, Flos Trollii 33g ~ 37g, Folium Isatidis 58g ~ 62g, Radix Isatidis 33g ~ 37g, Herba Violae 28g ~ 32g, Radix Astragali 28g ~ 32g, Radix Gentianae 33g ~ 37g, Fructus Viticis 13g ~ 17g, Concha Haliotidis 18g ~ 22g, Rhizoma Anemarrhenae 28g ~ 32g, Caulis Sinomenii 33g ~ 37g, Radix Ophiopogonis 28g ~ 32g, Coriolous Dersicolor (Fr.) Quel 18g ~ 22g, Herba Eleusines Indicae 18g ~ 22g, Herba Moslae Soochowensis 23g ~ 27g, Radix seu Herba Gei aleppici 33g 37g and Radix Talini Paniculati 28g ~ 32g.
Wherein, in described medicine the weight of each crude drug be respectively Radix Bupleuri 25g, Radix Saposhnikoviae 20g, Herba Houttuyniae 20g, Fructus Polygoni Orientalis 40g, Flos Trollii 35g, Folium Isatidis 60g, Radix Isatidis 35g, Herba Violae 30g, Radix Astragali 30g, Radix Gentianae 35g, Fructus Viticis 15g, Concha Haliotidis 20g, Rhizoma Anemarrhenae 30g, Caulis Sinomenii 35g, Radix Ophiopogonis 30g, Coriolous Dersicolor (Fr.) Quel 20g, Herba Eleusines Indicae 20g, Herba Moslae Soochowensis 25g, Radix seu Herba Gei aleppici 35g and Radix Talini Paniculati 30g.
Wherein, the dosage form of described medicine is injection.
The invention provides the preparation method of said medicine, be specially:
The first step, by Herba Houttuyniae, Fructus Polygoni Orientalis, Flos Trollii, Folium Isatidis, Radix Isatidis, Herba Violae, the Radix Astragali, Radix Gentianae, Concha Haliotidis, the Rhizoma Anemarrhenae, Radix Ophiopogonis, Radix seu Herba Gei aleppici and Radix Talini Paniculati are uniformly mixed according to above-mentioned weight, mixture after mix homogeneously being dissolved in determining alcohol is in the ethanol of 85% ~ 95%, the addition of the ethanol that every 100g mixture is corresponding is 300g, flood 24 hours ~ 36 hours, adopt percolation with the speed of 1 ~ 2ml per minute slowly percolation subsequently, collect percolate, percolate is evaporated to about 1/10 of original volume, adopt centrifuge, obtain supernatant, except desolventizing, pulverize and drying, obtain the first powder,
Part II, by remaining components by above-mentioned weight mixing, obtain mixture, add the water relative to mixture quality 2 ~ 4 times, decoct 3 ~ 5 hours, decoction liquor is filtered, and filtering residue adds the water relative to the mixture quality prepared 2 ~ 4 times again above, decoct 2 ~ 4 hours, decoction liquor is filtered, and twice decoction liquor is merged, add concentration be 10% salt acid for adjusting pH value be 3 ~ 4, static 2 ~ 4 hours, filter, filtrate alcohol extraction, extract concentrating under reduced pressure becomes dry mastic, dry, pulverize into the second powder subsequently;
3rd step, the fine powder mixing first step and second step obtained, gets 250g, add appropriate water for injection, stir 20min ~ 40min, adjust ph to 6.0 ~ 7.0, cold preservation 24 hours at the temperature of 0 DEG C ~ 4 DEG C, with 0.45 μm of membrane filtration, add water for injection to 1000ml, then use 0.45 μm of membrane filtration, fill is in injection bottle, sterilizing 30 minutes at 110 DEG C, obtains injection.
Beneficial effect of the present invention:
The medicine being used for the treatment of epidemic conjunctivitis provided by the invention is prepared into injection, adopts this injection administrated method simple, has no side effect, and rapid-action, effect is strong, length of holding time.
Detailed description of the invention
The invention provides a kind of medicine being used for the treatment of epidemic conjunctivitis, its crude drug comprises Radix Bupleuri, Radix Saposhnikoviae, Herba Houttuyniae, Fructus Polygoni Orientalis, Flos Trollii, Folium Isatidis, Radix Isatidis, Herba Violae, the Radix Astragali, Radix Gentianae, Fructus Viticis, Concha Haliotidis, the Rhizoma Anemarrhenae, Caulis Sinomenii, Radix Ophiopogonis, Coriolous Dersicolor (Fr.) Quel, Herba Eleusines Indicae, Herba Moslae Soochowensis, Radix seu Herba Gei aleppici and Radix Talini Paniculati.
Further, described medicine is only made up of above-mentioned raw materials medicine.
In described medicine, the weight of each crude drug is respectively Radix Bupleuri 20g ~ 30g, Radix Saposhnikoviae 15g ~ 25g, Herba Houttuyniae 15g ~ 25g, Fructus Polygoni Orientalis 35g ~ 45g, Flos Trollii 30g ~ 40g, Folium Isatidis 55g ~ 65g, Radix Isatidis 30g ~ 40g, Herba Violae 25g ~ 35g, Radix Astragali 25g ~ 35g, Radix Gentianae 30g ~ 40g, Fructus Viticis 10g ~ 20g, Concha Haliotidis 15g ~ 25g, Rhizoma Anemarrhenae 25g ~ 35g, Caulis Sinomenii 30g ~ 40g, Radix Ophiopogonis 25g ~ 35g, Coriolous Dersicolor (Fr.) Quel 15g ~ 25g, Herba Eleusines Indicae 15g ~ 25g, Herba Moslae Soochowensis 20g ~ 30g, Radix seu Herba Gei aleppici 30g ~ 40g and Radix Talini Paniculati 25g ~ 35g.
Further preferably, in described medicine, the weight of each crude drug is respectively Radix Bupleuri 23g ~ 27g, Radix Saposhnikoviae 18g ~ 22g, Herba Houttuyniae 18g ~ 22g, Fructus Polygoni Orientalis 38g ~ 42g, Flos Trollii 33g ~ 37g, Folium Isatidis 58g ~ 62g, Radix Isatidis 33g ~ 37g, Herba Violae 28g ~ 32g, Radix Astragali 28g ~ 32g, Radix Gentianae 33g ~ 37g, Fructus Viticis 13g ~ 17g, Concha Haliotidis 18g ~ 22g, Rhizoma Anemarrhenae 28g ~ 32g, Caulis Sinomenii 33g ~ 37g, Radix Ophiopogonis 28g ~ 32g, Coriolous Dersicolor (Fr.) Quel 18g ~ 22g, Herba Eleusines Indicae 18g ~ 22g, Herba Moslae Soochowensis 23g ~ 27g, Radix seu Herba Gei aleppici 33g 37g and Radix Talini Paniculati 28g ~ 32g.
Most preferably, in described medicine the weight of each crude drug be respectively Radix Bupleuri 25g, Radix Saposhnikoviae 20g, Herba Houttuyniae 20g, Fructus Polygoni Orientalis 40g, Flos Trollii 35g, Folium Isatidis 60g, Radix Isatidis 35g, Herba Violae 30g, Radix Astragali 30g, Radix Gentianae 35g, Fructus Viticis 15g, Concha Haliotidis 20g, Rhizoma Anemarrhenae 30g, Caulis Sinomenii 35g, Radix Ophiopogonis 30g, Coriolous Dersicolor (Fr.) Quel 20g, Herba Eleusines Indicae 20g, Herba Moslae Soochowensis 25g, Radix seu Herba Gei aleppici 35g and Radix Talini Paniculati 30g.
The pharmacology of described each crude drug is as follows:
Radix Bupleuri: latin name bupleuri radix, for the dry root of umbelliferae bupleurum or Radix Bupeuri Scorzonerfolii., cold nature, bitter in the mouth, pungent, return Liver Channel, gallbladder meridian, there is effect of heat radiation, sterilization, cure mainly cold, fever, alternate attack of chill and fever, malaria, stagnation of QI due to depression of the liver, sternal rib pain, proctoptosis, the cards such as uterus comes off, menoxenia.
Radix Saposhnikoviae: acrid in the mouth, sweet, slightly warm in nature, enters lung, liver, spleen, urinary bladder channel, has expelling cold and relieving exterior syndrome, removing dampness to relieve pain, expelling wind and relieving convulsion, antipruritic effect, is mainly used in affection of exogenous wind-cold card and cold-evil's closing, the syndrome of superficies cold and interior heat etc. of interior-heat pent-up.
Herba Houttuyniae: latin name houttuyniae herba, acrid in the mouth, cold nature, enters lung, urinary bladder channel, has heat-clearing and toxic substances removing, removing pus and relieving carbuncle, effect of inducing diuresis for treating stranguria syndrome, and for lung abscess vomiting pus, expectorant heat syndrome cough is breathed heavily, toxic-heat and blood stasis, damp-heat gonorrhoea, pyretic toxicity carbuncle sore, and snakeworm wants first-class card.
Fructus Polygoni Orientalis: taste becomes, and cold nature, returns liver, stomach warp, have effect of promoting flow of QI and blood, hard masses softening and resolving, cure mainly chronic hepatitis, cirrhotic ascites, the tuberculosis of cervical lymph nodes, splenomegaly, dyspepsia, abdomen amine is had a stomachache, food stagnation of child, the cards such as conjunctivitis.
Flos Trollii: latin name Trollius chinensis, bitter in the mouth, cool in nature, there is effect of heat-clearing and toxic substances removing, cure mainly acute and chronic tonsillitis, acute otitis media, acute myringitis, acute conjunctivitis, the cards such as acute lymphangitis.
Folium Isatidis: bitter in the mouth, property Great Cold, enter the heart, liver, gallbladder, stomach warp, have antipyretic and detoxicated, cooling blood and dissolving purpura, the effect of jaundice eliminating, can the excess-heat that divides of clearing heat in QI system, and can separate again the pyretic toxicity of blood system, the high febrile perspiration being mainly used in pestilence calentura caused goes out, excessive thirst taking fluids profusely; The speckle that fire-toxin is flourishing is gone mad, the symptoms such as haematemesis; The unconsciousness due to high fever of measles, rash color is purple dark; Dampness-heat in the liver and gallbladder accumulates the jaundice of steaming; The deafness and tinnitus of liver and gall fire liter; The card such as pharyngalgia, aphtha of the mouth and tongue, hepatitis that fire stagnation pyretic toxicity is caused.
Radix Isatidis: latin name Isatidis Radix, bitter in the mouth, cold in nature, enter the heart, liver, gallbladder, stomach warp, have the effect of heat-clearing and toxic substances removing, removing heat from blood sore-throat relieving, be used for the treatment of maculae caused by violent heat pathogen; High heat headache; Major part pestilence; Crimson tongue is purple dark, scarlet fever; Erysipelas; Mumps; Sore throat; Skin ulcer is swollen, carbuncle; Chickenpox; Measles; Hepatitis; Influenza, epidemic encephalitis, encephalitis b, pneumonia, coma tells nosebleed, pharyngeal swelling, acute catarrhal conjunctivitis, skin ulcer rash; The cards such as epidemic encephalitis type B, acute, chronic hepatitis, mumps, osteomyelitis can be prevented and treated.
Herba Violae: bitter in the mouth, pungent, cold in nature, enter the heart, Liver Channel, there is the effect of heat-clearing and toxic substances removing, removing heat from blood detumescence, be mainly used in the treatment for the treatment of furuncle carbuncle furuncle, also have good therapeutic effect to acute conjunctivitis, hordeolum etc., Herba Violae has inhibitory action in various degree to Staphyloccocus aureus, pneumobacillus, escherichia coli, alpha streptococcus, group B streptococcus, hemophilus influenza, diphtheria corynebacterium, bacillus pyocyaneus, white grapes sugar coccus, Candida albicans.
The Radix Astragali: latin name astragali radix, sweet in the mouth, warm in nature, return lung, spleen channel, have tonification spleen soil, elevate a turnable ladder yang-energy, strengthening superficial resistance to stop perspiration, the effects such as holder skin ulcer granulation promoting, are mainly used in treating the caused weak anorexia and loose stool of deficiency of both the splenic and pulmonary QI, shortness of breath and palpitation, the visceroptosis of sinking of QI of middle-JIAO, the metrorrhagia of QI failing to control blood is had blood in stool, chronic diarrhea proctoptosis; The spontaneous sweating of exterior deficiency; Insufficiency of vital energy and blood, yang-energy skin infection on the decline does not rise, difficulty in discharging of pus, burst and do not hold back for a long time; And the deficiency of vital energy loses the edema of fortune, the symptoms such as dysuria.
Radix Gentianae: bitter in the mouth, cold in nature, enters liver, gallbladder meridian, has heat clearing and damp drying, falls the effect of letting out liver-fire and function of gallbladder promoting, and the breast side of body being mainly used in dampness-heat of the liver caused is had a pain, and bitter taste is deaf, conjunctival congestion and swelling pain; Jaundice due to damp-heat; The dizzy order of flaming up of liver-fire swells; The high heat of liver-fire wind-transformation is through taking out; The card such as leucorrhea, dysuria of damp invasion of lower energizer.
Fructus Viticis: acrid in the mouth, hardship, cold nature, returns bladder, liver, stomach warp, has dispelling wind and heat pathogens, effect of the clear sharp head, cures mainly anemopyretic cold headache, gingivitis, the many tear of conjunctival congestion, poor vision, the card such as to have a dizzy spell.
Concha Haliotidis: taste becomes, and property is put down, and has effect of suppressing the hyperactive liver to relieve the wind syndrome, YANG hyperactivity suppressing, heat extraction improving eyesight, cures mainly the diseases such as excessive rising of liver-YANG, the vertigo, asthenia hectic fever due to YIN-deficiency, haematemesis, optic atrophy.
The Rhizoma Anemarrhenae: bitter in the mouth, sweet, cold in nature, enters lung, stomach, kidney channel, has relieving restlessness of purging heat, the effect of nourshing Yin and drynsessmoistening prescription, clearing away lung-heat to relieve cough, and cure mainly fever caused by exogenous pathogenic factors, high heat is irritated, lung-heat type cough, and interior-heat such as to be quenched one's thirst at the symptom; Its bitter cold matter is moistened, and property sedimentation can heat clearing away, can promote the production of body fluid again, kindly controls warm pathogenic factor and enters edema caused by disorder of QI, intenseness of heat impairment of body fluid; Also diabetes is used for the treatment of; Phlegm-heat obstructing in the lung and breathing heavily, xeropulmonary cough, expectorant is few unfavorable; Hyperactivity of fire caused by deficiency of YIN, the symptoms such as hyperactivity of deficient fire.
Caulis Sinomenii: bitter in the mouth, pungent, the cards such as property is put down, and return liver, spleen channel, have wind-damp dispelling, the meridian dredging, effect of diuresis, cures mainly rheumatic arthralgia, arthroncus, paralysis pruritus.
Radix Ophiopogonis: sweet in the mouth, micro-hardship, cold nature, enters the heart, lung, stomach warp, there is nourishing YIN and moistening the lung, effect that preventing phlegm from forming and stopping coughing, heat clearing away are nourished heart, cure mainly pathogenic dryness impairing the lung or lung-dryness syndrome due to deficiency of YIN has the dry cough expectorant of heat to stick, chronic cough hemoptysis, dry pharynx dryness in the nasal cavity, lung abscess, thermal burn stomach-Yin or the dry mouth and throat caused by deficiency of stomach-Yin, the few tongue of red tongue, vague epigastralgia, interior-heat is quenched one's thirst, constipation due to dry stool, deficiency of heart-yin and epidemic febrile disease pathogenic heat are disturbed and the heart-nutriment and the dysphoria and insomnia that causes, crimson tongue and dryly wait card.
Coriolous Dersicolor (Fr.) Quel: sweet in the mouth, light, cold nature, returns liver; Spleen; Lung meridian, has invigorating spleen to remove dampness; Relieving cough and asthma; Heat-clearing and toxic substances removing; Antineoplastic effect, cures mainly chronic active hepatitis; Hepatitis interstitialis chronica; Chronic bronchitis; Infantile spasm bronchitis; Laryngopharynx swelling and pain; Kinds of tumors; Rheumatoid arthritis; The cards such as leukemia.
Herba Eleusines Indicae: be root or the herb of grass family yard grass platymiscium Herba Eleusines Indicae, sweet in the mouth, light, cool in nature, there is heat-clearing and toxic substances removing, dampness removing, effect of cool the blood dissipate blood stasis, cure mainly Sunstroke heating, infantile convulsion, encephalitis b, epidemic encephalitis, jaundice, stranguria; dysuria, dysentery, has blood in stool, urticaria, the cards such as traumatic injury.
Herba Moslae Soochowensis: warm in nature, acrid in the mouth, has dispelling summer-heat from superficies of the body, and effect of regulating QI to relieve pain, cures mainly flu, heatstroke, eruptive disease, peratodynia, the cards such as laryngopharynx swelling and pain.
Radix seu Herba Gei aleppici: latin name Gei Herba, acrid in the mouth, hardship, property is put down, and return liver, spleen, lung meridian, have analgesia, blood pressure lowering, regulating menstruation, effect of expelling wind and removing dampness, cures mainly hypertension, dizziness headache, menoxenia, lower abdominal pain, leucorrhea, infantile convulsion, lumbago, skelalgia of rheumatism; Carbuncle furuncle and phyma poison is controlled in external, the cards such as traumatic injury.
Radix Talini Paniculati: latin name Pedicularis muscicola Maxim, sweet in the mouth, micro-hardship, tool heat-clearing toxin-expelling functions, weak to the deficiency of vital energy, diarrhea due to hypofunction of the spleen, xeropulmonary cough, neurasthenia etc. have certain curative effect.Strongly invigorating primordial QI, promoting the production of body fluid and inducing sedation of the mind, heart tonifying.Control QI and blood deficient, asthenia hyperhidrosis, collapse exhaustion, blood pressure reduces.
Because primary disease is with obvious General Symptoms, therefore systemic administration is real is necessary.Therefore, medicine provided by the invention is based on systemic administration, and the dosage form provided is injection.
The invention provides the preparation method of said medicine, be specially:
The first step, by Herba Houttuyniae, Fructus Polygoni Orientalis, Flos Trollii, Folium Isatidis, Radix Isatidis, Herba Violae, the Radix Astragali, Radix Gentianae, Concha Haliotidis, the Rhizoma Anemarrhenae, Radix Ophiopogonis, Radix seu Herba Gei aleppici and Radix Talini Paniculati are uniformly mixed according to above-mentioned weight, mixture after mix homogeneously being dissolved in determining alcohol is in the ethanol of 85% ~ 95%, the addition of the ethanol that every 100g mixture is corresponding is 300g, flood 24 hours ~ 36 hours, adopt percolation with the speed of 1 ~ 2ml per minute slowly percolation subsequently, collect percolate, percolate is evaporated to about 1/10 of original volume, adopt centrifuge, obtain supernatant, except desolventizing, pulverize and drying, obtain the first powder,
Part II, by remaining components by above-mentioned weight mixing, obtain mixture, add the water relative to mixture quality 2 ~ 4 times, decoct 3 ~ 5 hours, decoction liquor is filtered, and filtering residue adds the water relative to the mixture quality prepared 2 ~ 4 times again above, decoct 2 ~ 4 hours, decoction liquor is filtered, and twice decoction liquor is merged, add concentration be 10% salt acid for adjusting pH value be 3 ~ 4, static 2 ~ 4 hours, filter, filtrate alcohol extraction, extract concentrating under reduced pressure becomes dry mastic, dry, pulverize into the second powder subsequently;
3rd step, the powder mixing first step and second step obtained, gets 250g, add appropriate water for injection, stir 20min ~ 40min, adjust ph to 6.0 ~ 7.0, cold preservation 24 hours at the temperature of 0 DEG C ~ 4 DEG C, with 0.45 μm of membrane filtration, add water for injection to 1000ml, then use 0.45 μm of membrane filtration, fill is in injection bottle, sterilizing 30 minutes at 110 DEG C, obtains injection.
Below adopt embodiment to describe embodiments of the present invention in detail, to the present invention, how application technology means solve technical problem whereby, and the implementation procedure reaching technique effect can fully understand and implement according to this.
Embodiment 1 injection 1
By Herba Houttuyniae 20g, Fructus Polygoni Orientalis 40g, Flos Trollii 35g, Folium Isatidis 60g, Radix Isatidis 35g, Herba Violae 30g, Radix Astragali 30g, Radix Gentianae 35g, Concha Haliotidis 20g, Rhizoma Anemarrhenae 30g, Radix Ophiopogonis 30g, Radix seu Herba Gei aleppici 35g and Radix Talini Paniculati 30g is uniformly mixed, and the mixture after mix homogeneously being dissolved in determining alcohol is in the ethanol of 95%, and the addition of the ethanol that every 100g mixture is corresponding is 300g, flood 36 hours, adopt percolation with the speed of 2ml per minute slowly percolation subsequently, collect percolate, percolate is evaporated to about 1/10 of original volume, adopt centrifuge, obtain supernatant, except desolventizing, pulverize and drying, obtain the first powder, by Radix Bupleuri 25g, Radix Saposhnikoviae 20g, Fructus Viticis 15g, Caulis Sinomenii 35g, Coriolous Dersicolor (Fr.) Quel 20g, Herba Eleusines Indicae 20g, Herba Moslae Soochowensis 25g mixes, and obtains mixture, adds the water of 450g, decoct 4 hours, decoction liquor is filtered, and filtering residue adds the water of 450g again, decoct 3 hours, decoction liquor is filtered, and twice decoction liquor is merged, add concentration be 10% salt acid for adjusting pH value be 3, static 3 hours, filter, filtrate alcohol extraction, extract concentrating under reduced pressure becomes dry mastic, dry, pulverize into the second powder subsequently, by the powder mixing obtained above, get 250g, add appropriate water for injection, stir 30min, adjust ph to 7.0, cold preservation 24 hours at the temperature of 0 DEG C, with 0.45 μm of membrane filtration, adds water for injection to 1000ml, use 0.45 μm of membrane filtration again, fill is in injection bottle, and sterilizing 30 minutes at 110 DEG C, obtains injection 1.
Embodiment 2 injection 2
By Herba Houttuyniae 18g, Fructus Polygoni Orientalis 38g, Flos Trollii 33g, Folium Isatidis 58g, Radix Isatidis 33g, Herba Violae 28g, Radix Astragali 28g, Radix Gentianae 33g, Concha Haliotidis 18g, Rhizoma Anemarrhenae 28g, Radix Ophiopogonis 28g, Radix seu Herba Gei aleppici 33g and Radix Talini Paniculati 28g is uniformly mixed, and the mixture after mix homogeneously being dissolved in determining alcohol is in the ethanol of 95%, and the addition of the ethanol that every 100g mixture is corresponding is 300g, flood 36 hours, adopt percolation with the speed of 2ml per minute slowly percolation subsequently, collect percolate, percolate is evaporated to about 1/10 of original volume, adopt centrifuge, obtain supernatant, except desolventizing, pulverize and drying, obtain the first powder, by Radix Bupleuri 23g, Radix Saposhnikoviae 18g, Fructus Viticis 13g, Caulis Sinomenii 33g, Coriolous Dersicolor (Fr.) Quel 18g, Herba Eleusines Indicae 18g, Herba Moslae Soochowensis 23g mixes, and obtains mixture, adds the water of 450g, decoct 4 hours, decoction liquor is filtered, and filtering residue adds the water of 450g again, decoct 3 hours, decoction liquor is filtered, and twice decoction liquor is merged, add concentration be 10% salt acid for adjusting pH value be 3, static 3 hours, filter, filtrate alcohol extraction, extract concentrating under reduced pressure becomes dry mastic, dry, pulverize into the second powder subsequently, by the powder mixing obtained above, get 250g, add appropriate water for injection, stir 30min, adjust ph to 7.0, cold preservation 24 hours at the temperature of 0 DEG C, with 0.45 μm of membrane filtration, adds water for injection to 1000ml, use 0.45 μm of membrane filtration again, fill is in injection bottle, and sterilizing 30 minutes at 110 DEG C, obtains injection 2.
Embodiment 3 injection 3
By Herba Houttuyniae 22g, Fructus Polygoni Orientalis 42g, Flos Trollii 37g, Folium Isatidis 62g, Radix Isatidis 37g, Herba Violae 32g, Radix Astragali 32g, Radix Gentianae 37g, Concha Haliotidis 22g, Rhizoma Anemarrhenae 32g, Radix Ophiopogonis 32g, Radix seu Herba Gei aleppici 37g and Radix Talini Paniculati 32g is uniformly mixed, and the mixture after mix homogeneously being dissolved in determining alcohol is in the ethanol of 95%, and the addition of the ethanol that every 100g mixture is corresponding is 300g, flood 36 hours, adopt percolation with the speed of 2ml per minute slowly percolation subsequently, collect percolate, percolate is evaporated to about 1/10 of original volume, adopt centrifuge, obtain supernatant, except desolventizing, pulverize and drying, obtain the first powder, by Radix Bupleuri 27g, Radix Saposhnikoviae 22g, Fructus Viticis 17g, Caulis Sinomenii 37g, Coriolous Dersicolor (Fr.) Quel 22g, Herba Eleusines Indicae 22g, Herba Moslae Soochowensis 27g mixes, and obtains mixture, adds the water of 450g, decoct 4 hours, decoction liquor is filtered, and filtering residue adds the water of 450g again, decoct 3 hours, decoction liquor is filtered, and twice decoction liquor is merged, add concentration be 10% salt acid for adjusting pH value be 3, static 3 hours, filter, filtrate alcohol extraction, extract concentrating under reduced pressure becomes dry mastic, dry, pulverize into the second powder subsequently, by the powder mixing obtained above, get 250g, add appropriate water for injection, stir 30min, adjust ph to 7.0, cold preservation 24 hours at the temperature of 0 DEG C, with 0.45 μm of membrane filtration, adds water for injection to 1000ml, use 0.45 μm of membrane filtration again, fill is in injection bottle, and sterilizing 30 minutes at 110 DEG C, obtains injection 3.
Embodiment 4 toxicology test
General pharmacology is tested
To injection 1 100ml/kg prepared by the present invention of sobering animal K.M kind injected in mice, observe 7 days, result voluntary activity is normal, Neurotoxicity is without obvious excited or suppression phenomenon, hair is smooth, diet, feces no abnormality seen, illustrate that injection of the present invention all has no side effect to nervous system, cardiovascular system respiratory system of unifying.
3, long term toxicity test: domesticated dog 60, injection group 40, often organize 20, injection 0.2/kg and lg/kg90 days of the continuous intravenous injection embodiment of the present invention 1 preparation respectively, matched group is not injected, experimental session, and each treated animal has no poisoning symptom, activity, behavior, diet, feces no abnormality seen, body weight increases with matched group close; Within 10 days, measure electrocardiogram, hematology, blood biochemical, urinalysis 25 test items respectively after 45 days and 90 days and drug withdrawal before administration, after administration, result medication two groups is basically identical with matched group; Medication after 90 days and after drug withdrawal 10 days, to heavy dose of 8, middle dosage 6, matched group 6, carries out 12 organ coefficients and 25 histology's microscopies, is showed no exception; Animal behavior no abnormality seen after drug withdrawal, illustrates that injection of the present invention is without savings intoxication.
Injection 1 prepared by the embodiment of the present invention 1 under 0.2g/kg and 1.0g/kg over much dosage (than the large 35-175 of clinical dosage doubly, than the large 20-100 of animal effective dose doubly) to domesticated dog continuous intravenous injection 90 days, observation is continued 10 days after drug withdrawal, experimental session, each treated animal has been showed no poisoning symptom.The activity of animal, behavior, diet, feces have no abnormal changes.Body weight growth pattern close with matched group (P > 0.05).Before in after and when checking for four times after drug withdrawal, medication two groups and matched group are basically identical.Pathological examination, medication is after 90 days and drug withdrawal after 10 days, and check heavy dose of 8 altogether, middle dosage 6, matched group 6,12 organ coefficients and 25 histology's microscopies, be showed no exception.Prompting: liver is likely toxicity target organ.After drug withdrawal, animal behavior has no morbidity phenomenon, and within the 10th day, provocative test result is negative.
Above-mentioned experimental data shows: Chinese medicine injection long term toxicity of the present invention is very little, is very safe.
Embodiment 5 clinical data
Physical data
Epidemic keratitis patient totally 159 examples that in October, 2012 ~ 2013 year December is accepted for medical treatment, ill eye number is 261, and patient age is minimum is 8 years old, and be 69 years old to the maximum, disease time the shortest is 2 days, and the longest is 28 days.Patient is divided into treatment group and matched group at random, treatment group patient 80 example, ill eye number is 135, matched group patient 79 example, several 126 of ill eye.
Diagnostic criteria
Two groups of case diagnosis are all according to " Chinese medical disease Standardization of diagnosis and curative effect " that State Administration of Traditional Chinese Medicine issues.
Therapeutic Method
The injection 1 that treatment group adopts the embodiment of the present invention 1 to prepare, every bottle of 100ml, adds 5% glucose injection 200ml at every turn and dilutes latter quiet by 100ml injection 1,30 per minute, every day 1 time, inject 7 days, matched group quiet Ribavirin presses the consumption of 70mg/kg, every day 1 time.According to pharmacopoeial requirements, limit the use of 7 days.
Two groups all use 50% Herba Houttuyniae eye liquid and 0.5% virazole eye drop to suffer from eye, every day 5 times, and oral vitamin C 0.2g and compound vitamin B while injection
2sheet, every day 3 times.
Criterion of therapeutical effect
Efficacy evaluation is with reference to " Chinese medical disease Standardization of diagnosis and curative effect ".Cure: subjective symptoms disappears, eyelid, bulbar conjunctiva are without hyperemia, edema and folliculus, and corneal fluorescein dyeing is for negative.Take a turn for the better: subjective symptoms is slight, eyelid, bulbar conjunctiva mild hyperaemia, corneal fluorescein dyeing is (-) or (±).Do not heal: the eye state of an illness is unchanged or increase the weight of.
Statistical method
Measurement data adopts
represent, compare between group and adopt χ
2inspection, all data all adopt the process of SPSS12.0 statistical software.
Result
Two groups of general curative effects compare, and the results are shown in Table 1.
Table 1 liang group overall patient comparitive study
Group | N (eye) | Cure | Take a turn for the better | Invalid | Cure rate/% |
Treatment group | 135 | 112 | 23 | 0 | 82.9 |
Matched group | 126 | 82 | 44 | 0 | 65.1 |
As can be seen from Table 1, adopt the therapeutic effect of medicine provided by the invention will significantly better than the therapeutic effect of matched group medicine, p < 0.05.
Cure patient treatment Annual distribution, in table 2 for two groups.
A table 2 liang group cures patient treatment Annual distribution
Group | N (eye) | 1~3d | 4~5d | 6~7d |
Treatment group | 135 | 63 | 49 | 23 |
Matched group | 126 | 37 | 43 | 46 |
All above-mentioned this intellectual properties of primary enforcement, not setting restriction this new product of other forms of enforcement and/or new method.Those skilled in the art will utilize this important information, and foregoing is revised, to realize similar implementation status.But all modifications or transformation belong to the right of reservation based on new product of the present invention.
The above is only preferred embodiment of the present invention, and be not restriction the present invention being made to other form, any those skilled in the art may utilize the technology contents of above-mentioned announcement to be changed or be modified as the Equivalent embodiments of equivalent variations.But everyly do not depart from technical solution of the present invention content, any simple modification, equivalent variations and the remodeling done above embodiment according to technical spirit of the present invention, still belong to the protection domain of technical solution of the present invention.
Claims (6)
1. be used for the treatment of a medicine for epidemic conjunctivitis, it is characterized in that: crude drug comprises Radix Bupleuri, Radix Saposhnikoviae, Herba Houttuyniae, Fructus Polygoni Orientalis, Flos Trollii, Folium Isatidis, Radix Isatidis, Herba Violae, the Radix Astragali, Radix Gentianae, Fructus Viticis, Concha Haliotidis, the Rhizoma Anemarrhenae, Caulis Sinomenii, Radix Ophiopogonis, Coriolous Dersicolor (Fr.) Quel, Herba Eleusines Indicae, Herba Moslae Soochowensis, Radix seu Herba Gei aleppici and Radix Talini Paniculati.
2. medicine as claimed in claim 1, it is characterized in that: the weight of each crude drug is respectively Radix Bupleuri 20g ~ 30g, Radix Saposhnikoviae 15g ~ 25g, Herba Houttuyniae 15g ~ 25g, Fructus Polygoni Orientalis 35g ~ 45g, Flos Trollii 30g ~ 40g, Folium Isatidis 55g ~ 65g, Radix Isatidis 30g ~ 40g, Herba Violae 25g ~ 35g, Radix Astragali 25g ~ 35g, Radix Gentianae 30g ~ 40g, Fructus Viticis 10g ~ 20g, Concha Haliotidis 15g ~ 25g, Rhizoma Anemarrhenae 25g ~ 35g, Caulis Sinomenii 30g ~ 40g, Radix Ophiopogonis 25g ~ 35g, Coriolous Dersicolor (Fr.) Quel 15g ~ 25g, Herba Eleusines Indicae 15g ~ 25g, Herba Moslae Soochowensis 20g ~ 30g, Radix seu Herba Gei aleppici 30g ~ 40g and Radix Talini Paniculati 25g ~ 35g.
3. medicine as claimed in claim 1 or 2, it is characterized in that: the weight of each crude drug is respectively Radix Bupleuri 23g ~ 27g, Radix Saposhnikoviae 18g ~ 22g, Herba Houttuyniae 18g ~ 22g, Fructus Polygoni Orientalis 38g ~ 42g, Flos Trollii 33g ~ 37g, Folium Isatidis 58g ~ 62g, Radix Isatidis 33g ~ 37g, Herba Violae 28g ~ 32g, Radix Astragali 28g ~ 32g, Radix Gentianae 33g ~ 37g, Fructus Viticis 13g ~ 17g, Concha Haliotidis 18g ~ 22g, Rhizoma Anemarrhenae 28g ~ 32g, Caulis Sinomenii 33g ~ 37g, Radix Ophiopogonis 28g ~ 32g, Coriolous Dersicolor (Fr.) Quel 18g ~ 22g, Herba Eleusines Indicae 18g ~ 22g, Herba Moslae Soochowensis 23g ~ 27g, Radix seu Herba Gei aleppici 33g 37g and Radix Talini Paniculati 28g ~ 32g.
4. the medicine as described in claims 1 to 3, is characterized in that: the weight of each crude drug be respectively Radix Bupleuri 25g, Radix Saposhnikoviae 20g, Herba Houttuyniae 20g, Fructus Polygoni Orientalis 40g, Flos Trollii 35g, Folium Isatidis 60g, Radix Isatidis 35g, Herba Violae 30g, Radix Astragali 30g, Radix Gentianae 35g, Fructus Viticis 15g, Concha Haliotidis 20g, Rhizoma Anemarrhenae 30g, Caulis Sinomenii 35g, Radix Ophiopogonis 30g, Coriolous Dersicolor (Fr.) Quel 20g, Herba Eleusines Indicae 20g, Herba Moslae Soochowensis 25g, Radix seu Herba Gei aleppici 35g and Radix Talini Paniculati 30g.
5. the medicine as described in Claims 1-4, is characterized in that: the dosage form of described medicine is injection.
6. the preparation method of medicine described in Claims 1-4, is characterized in that, comprising:
The first step, by Herba Houttuyniae, Fructus Polygoni Orientalis, Flos Trollii, Folium Isatidis, Radix Isatidis, Herba Violae, the Radix Astragali, Radix Gentianae, Concha Haliotidis, the Rhizoma Anemarrhenae, Radix Ophiopogonis, Radix seu Herba Gei aleppici and Radix Talini Paniculati are uniformly mixed according to above-mentioned weight, mixture after mix homogeneously being dissolved in determining alcohol is in the ethanol of 85% ~ 95%, the addition of the ethanol that every 100g mixture is corresponding is 300g, flood 24 hours ~ 36 hours, adopt percolation with the speed of 1 ~ 2ml per minute slowly percolation subsequently, collect percolate, percolate is evaporated to about 1/10 of original volume, adopt centrifuge, obtain supernatant, except desolventizing, pulverize and drying, obtain the first powder,
Part II, by component under She by above-mentioned weight mixing, obtain mixture, add the water relative to mixture quality 2 ~ 4 times, decoct 3 ~ 5 hours, decoction liquor is filtered, and filtering residue adds the water relative to the mixture quality prepared 2 ~ 4 times again above, decoct 2 ~ 4 hours, decoction liquor is filtered, and twice decoction liquor is merged, add concentration be 10% salt acid for adjusting pH value be 3 ~ 4, static 2 ~ 4 hours, filter, filtrate alcohol extraction, extract concentrating under reduced pressure becomes dry mastic, dry, pulverize into the second powder subsequently;
3rd step, the fine powder mixing first step and second step obtained, gets 250g, add appropriate water for injection, stir 20min ~ 40min, adjust ph to 6.0 ~ 7.0, cold preservation 24 hours at the temperature of 0 DEG C ~ 4 DEG C, with 0.45 μm of membrane filtration, add water for injection to 1000ml, then use 0.45 μm of membrane filtration, fill is in injection bottle, sterilizing 30 minutes at 110 DEG C, obtains injection.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410588953.4A CN104383314A (en) | 2014-10-28 | 2014-10-28 | Medicine for treating epidemic keratitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410588953.4A CN104383314A (en) | 2014-10-28 | 2014-10-28 | Medicine for treating epidemic keratitis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104383314A true CN104383314A (en) | 2015-03-04 |
Family
ID=52601338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410588953.4A Pending CN104383314A (en) | 2014-10-28 | 2014-10-28 | Medicine for treating epidemic keratitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104383314A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105362484A (en) * | 2015-11-25 | 2016-03-02 | 禤燕华 | Traditional Chinese medicine composition for treating keratitis and preparation method thereof |
CN105998240A (en) * | 2016-07-03 | 2016-10-12 | 张俊清 | Mongolian medicine composition for curing pinkeye |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1317335A (en) * | 2001-02-01 | 2001-10-17 | 张震寰 | Medical pill for improving vision and clearing liver heat away |
CN1394624A (en) * | 2001-07-11 | 2003-02-05 | 石巧芝 | Chinese medicine prescription for curing eye disease and its preparation method |
CN101164579A (en) * | 2007-09-20 | 2008-04-23 | 吴月 | Traditional Chinese medicine for treating keratitis |
-
2014
- 2014-10-28 CN CN201410588953.4A patent/CN104383314A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1317335A (en) * | 2001-02-01 | 2001-10-17 | 张震寰 | Medical pill for improving vision and clearing liver heat away |
CN1394624A (en) * | 2001-07-11 | 2003-02-05 | 石巧芝 | Chinese medicine prescription for curing eye disease and its preparation method |
CN101164579A (en) * | 2007-09-20 | 2008-04-23 | 吴月 | Traditional Chinese medicine for treating keratitis |
Non-Patent Citations (4)
Title |
---|
张文康: "《中西医结合医学》", 30 June 2000 * |
朱晓林: "基于频数分析的明代角膜炎用药规律研究", 《四川中医》 * |
朱晓林: "近现代角膜炎用药规律聚类分析研究", 《山西中医》 * |
赵桂霞: "鱼腥草注射液治疗病毒性角膜炎疗效观察", 《中国中医眼科杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105362484A (en) * | 2015-11-25 | 2016-03-02 | 禤燕华 | Traditional Chinese medicine composition for treating keratitis and preparation method thereof |
CN105998240A (en) * | 2016-07-03 | 2016-10-12 | 张俊清 | Mongolian medicine composition for curing pinkeye |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103656290B (en) | Medicine for treating optic atrophy and preparation method of medicine | |
CN104189789A (en) | Traditional Chinese medicine composition for treating acute infectious jaundice type hepatitis | |
CN103007014B (en) | Traditional Chinese medicine composition used for treating xerophthalmia and preparation method thereof | |
CN102743618B (en) | Preparation method of Chinese medicine irrigation solution for treating urethral orifice burning type senile vaginitis | |
CN103721000A (en) | Medicinal preparation for treating epidemic keratoconjunctivitis | |
CN102961521A (en) | Drug for treating herpes simplex virus keratities | |
CN103120760B (en) | Traditional Chinese medicine composition for treating acute sinusitis and preparation method thereof | |
CN104398938A (en) | Traditional Chinese medicine for treating wind-heat invading lung lobar pneumonia and preparation method | |
CN104383314A (en) | Medicine for treating epidemic keratitis | |
CN104258252A (en) | Pharmaceutical composition for treating duck virus hepatitis and preparation method thereof | |
CN104491199A (en) | Traditional Chinese medicine preparation for treating nasosinusitis and preparation method thereof | |
CN103585472A (en) | Traditional Chinese medicine for treating chronic hypertrophic pharyngitis | |
CN102743613A (en) | Preparation method of Chinese medicine irrigation solution for treating stomach-yin deficiency type senile vaginitis | |
CN103028041B (en) | Traditional Chinese medicine composition for treating acute nasosinusitis of children and preparation method of traditional Chinese medicine composition | |
CN103028040B (en) | Traditional Chinese medicine composition for treating infantile chronic nasosinusitis and preparation method of traditional Chinese medicine composition | |
CN102920911B (en) | Traditional Chinese medicine for treating keratoconjunctivitis sicca and preparation method thereof | |
CN104257916A (en) | Medicament for treating allergic conjunctivitis | |
CN104887950A (en) | Mastitis treatment traditional Chinese medicine compound | |
CN104352794A (en) | Traditional Chinese medicine preparation for treating lung yin deficiency type xerophthalmia | |
CN104352995A (en) | Medicine for treating gall-stone and preparation method thereof | |
CN104606661A (en) | Traditional Chinese medicinal galactagogue for treating hypogalactia after cesarean delivery and preparation method of galactagogue | |
CN103800822A (en) | Traditional Chinese medicinal composition for treating hypertensive cerebral hemorrhage | |
CN103041172B (en) | Traditional Chinese medicine composition for curing chronic nasosinusitis and preparation method thereof | |
CN105477473A (en) | Medicament for treating herpes simplex keratitis | |
CN104367942A (en) | Traditional Chinese medicine for treating lobar pneumonia with syndrome of phlegm-heat obstructing lung in children and preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150304 |